News & Articles

Results per page

Selected Filters:

Biopharmaceutical Advances Clear Filters

Industry News

Phico Therapeutics Awarded Innovate UK Funding for £1.4 Million ($1.87M) Antibacterial Therapy Project

31 Jul 2018

Industry News

New Method Reveals How Well Cancer Drugs Hit Their Targets

19 Jul 2018

Industry News

Dual Mechanism Inhibitor Against Chronic Lymphocytic Leukemia Announced

19 Jul 2018

Product News

New Range of Flush Solutions Designed to Improve Analytical Instrument Performance

7 Jun 2018

Industry News

Cancer Fighting Effects of Aspirin Revealed in Bowel Tumor Study

5 Jun 2018

Product News

New Accessories for Testing Nebulisers with Facemasks

3 Jun 2018

Expert Insights

Free Webinar: Kinetic Characterization of Covalent Inhibitors on the PHERAstar

29 May 2018

Product News

SCIEX Announces New BioPharmaView Software 3.0 for Streamlining Multiple-Attribute Methods (MAM)

24 May 2018

Product News

New Protein Characterization Instrument System Transforms Biotherapeutic Analysis

13 May 2018

Industry News

Thermo Fisher Scientific Signs New Agreements to Expand Oncomine Dx Target Test

10 May 2018

Product News

Thermo Fisher Scientific Unveils Gibco ExpiSf System

3 May 2018

Industry News

A Collaboration of Giants for Cancer Research

19 Apr 2018

Industry News

Funding Gift Program Announced for Cancer Research Breakthroughs

19 Apr 2018

Industry News

BioAscent Establishes Integrated Drug Discovery Solutions

19 Apr 2018

Product News

Copley Scientific to Present Albuterol Products at Respiratory Drug Delivery 2018

19 Apr 2018

Industry News

Novel Therapy Aims to Combine TLR9 Agonist with Pembrolizumab for Improved Outcome

17 Apr 2018

Industry News

Dual Inhibition of IDO1 and PD-L1 Safe in Patients with Advanced Solid Tumors

17 Apr 2018

Industry News

Results for CheckMate -277 Phase III Clinical Trial Presented at AACR 2018

16 Apr 2018

Industry News

New Trial Indicates Safe & Effective Neoadjuvant Treatment for Lung Cancer

16 Apr 2018

Industry News

Developing a New Therapeutic for Tuberculosis

16 Apr 2018

Industry News

Selective Inhibitor BLU-667 Demonstrates Early Promise in Patients With RET-Altered Cancers

15 Apr 2018

Industry News

HER2 Mutations Linked to Tumor Survival Post Hormone Therapy

12 Apr 2018

Industry News

American Association for Cancer Research Announces Class of Fellows of the AACR Academy

12 Apr 2018

Industry News

Odilorhabdins Bind to Ribosomes and Disrupt Protein Synthesis in Bacteria

5 Apr 2018

Industry News

Successful Phase 2b Study Results for GNbAC1 in Multiple Sclerosis

25 Mar 2018

News & Articles

Articles Filter

Search

Selected Filters:

Phico Therapeutics Awarded Innovate UK Funding for £1.4 Million ($1.87M) Antibacterial Therapy Project

New Method Reveals How Well Cancer Drugs Hit Their Targets

Dual Mechanism Inhibitor Against Chronic Lymphocytic Leukemia Announced

New Range of Flush Solutions Designed to Improve Analytical Instrument Performance

Cancer Fighting Effects of Aspirin Revealed in Bowel Tumor Study

New Accessories for Testing Nebulisers with Facemasks

Free Webinar: Kinetic Characterization of Covalent Inhibitors on the PHERAstar

SCIEX Announces New BioPharmaView Software 3.0 for Streamlining Multiple-Attribute Methods (MAM)

New Protein Characterization Instrument System Transforms Biotherapeutic Analysis

Thermo Fisher Scientific Signs New Agreements to Expand Oncomine Dx Target Test

Thermo Fisher Scientific Unveils Gibco ExpiSf System

A Collaboration of Giants for Cancer Research

Funding Gift Program Announced for Cancer Research Breakthroughs

BioAscent Establishes Integrated Drug Discovery Solutions

Copley Scientific to Present Albuterol Products at Respiratory Drug Delivery 2018

Novel Therapy Aims to Combine TLR9 Agonist with Pembrolizumab for Improved Outcome

Dual Inhibition of IDO1 and PD-L1 Safe in Patients with Advanced Solid Tumors

Results for CheckMate -277 Phase III Clinical Trial Presented at AACR 2018

New Trial Indicates Safe & Effective Neoadjuvant Treatment for Lung Cancer

Developing a New Therapeutic for Tuberculosis

Selective Inhibitor BLU-667 Demonstrates Early Promise in Patients With RET-Altered Cancers

HER2 Mutations Linked to Tumor Survival Post Hormone Therapy

American Association for Cancer Research Announces Class of Fellows of the AACR Academy

Odilorhabdins Bind to Ribosomes and Disrupt Protein Synthesis in Bacteria

Successful Phase 2b Study Results for GNbAC1 in Multiple Sclerosis

News & Articles

Articles FilterArticles Filter

Search

Selected Filters:

Phico Therapeutics Awarded Innovate UK Funding for £1.4 Million ($1.87M) Antibacterial Therapy Project

New Method Reveals How Well Cancer Drugs Hit Their Targets

Dual Mechanism Inhibitor Against Chronic Lymphocytic Leukemia Announced

New Range of Flush Solutions Designed to Improve Analytical Instrument Performance

Cancer Fighting Effects of Aspirin Revealed in Bowel Tumor Study

New Accessories for Testing Nebulisers with Facemasks

Free Webinar: Kinetic Characterization of Covalent Inhibitors on the PHERAstar

SCIEX Announces New BioPharmaView Software 3.0 for Streamlining Multiple-Attribute Methods (MAM)

New Protein Characterization Instrument System Transforms Biotherapeutic Analysis

Thermo Fisher Scientific Signs New Agreements to Expand Oncomine Dx Target Test

Thermo Fisher Scientific Unveils Gibco ExpiSf System

A Collaboration of Giants for Cancer Research

Funding Gift Program Announced for Cancer Research Breakthroughs

BioAscent Establishes Integrated Drug Discovery Solutions

Copley Scientific to Present Albuterol Products at Respiratory Drug Delivery 2018

Novel Therapy Aims to Combine TLR9 Agonist with Pembrolizumab for Improved Outcome

Dual Inhibition of IDO1 and PD-L1 Safe in Patients with Advanced Solid Tumors

Results for CheckMate -277 Phase III Clinical Trial Presented at AACR 2018

New Trial Indicates Safe & Effective Neoadjuvant Treatment for Lung Cancer

Developing a New Therapeutic for Tuberculosis

Selective Inhibitor BLU-667 Demonstrates Early Promise in Patients With RET-Altered Cancers

HER2 Mutations Linked to Tumor Survival Post Hormone Therapy

American Association for Cancer Research Announces Class of Fellows of the AACR Academy

Odilorhabdins Bind to Ribosomes and Disrupt Protein Synthesis in Bacteria

Successful Phase 2b Study Results for GNbAC1 in Multiple Sclerosis

Articles Filter